Clinical Trial Update: A Multicenter Comparative Study of the ReCell Device and Autologous Split-thickness Meshed Skin Graft in the Treatment of Acute Burn Injuries [NA]

View source ↗

Summary

A multicenter trial comparing the ReCell device with autologous split-thickness meshed skin graft in acute burn injuries has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Burns

Drugs mentioned

• ReCell device

Snippet

Sponsor: Avita Medical | Conditions: Burns | NA | Status: COMPLETED | Results posted: 2019-05-13